Appointment

Dr. Wassim Shatila

Interventional Cardiology Consultant

Book An Appointment
Locations
CMC Hospital – DHCC 2
Languages
English Arabic

Bio

Dr. Wassim Shatila is an American Board Certified Interventional Cardiologist in charge of our structural cardiology program.

He received his American Board of Cardiology in 2017 and his American Board of Interventional Cardiology in 2018.

After completing his medical school, he finished his residency in Internal Medicine at Duke University Medical Center which is one of the top hospitals in the USA. He then completed his fellowship in cardiology and interventional cardiology at Texas Heart Institute/Baylor College of Medicine. The latter is a top heart center where the first heart transplant has been performed and largest cardiac catheterization lab was housed.

Dr. Shatila specializes in performing complex cardiac procedures including coronary, structural, and peripheral/vascular interventions without the need for surgery. These procedures include non-invasive valve replacement or repair (TAVI, mitral valvuplasty, among others), cardiac defect repair (ASD, PFO), aortic therapies (EVAR for aneurysm repair), venous therapies (varicose vein ablation), and complex coronary interventions (CTO therapy, among others).

Dr. Shatila also acquired the American Board of Internal Medicine in 2014, American Board of Echocardiography in 2017, and American Board of Nuclear Cardiology in 2018.

In addition to completing his training in prominent institutions in North America, Dr Shatila has over 25 peer reviewed medial publications. He is a Fellow in both the American College of Cardiology and the Society for Cardiovascular and Interventions.

Publications
  1. Shatila W, Krajcer Z. Myocardial fibrosis and MitraClip: Does it even matter? Catheter Cardiovasc Interv. 2019 May 1;93(6):1150-1151.
  2. Shatila W, Krajcer Z. TAVI: How to best predict postprocedural outcomes? Catheter Cardiovasc Interv. 2019 Mar 1;93(4):E261.
  3. Shatila W, Krajcer Z. Does single-valve surgery cause ischemia? Catheter Cardiovasc Interv. 2019 Mar 1;93(4):590-591.
  4. Shatila W, Krajcer Z. Plug vs. suture: Who wins in large bore access closure? Catheter Cardiovasc Interv. 2018 Nov 1;92(5):962-963.
  5. Shatila W, Krajcer Z. Aortic dissection: Is the false lumen really important? Catheter Cardiovasc Interv. 2018 Oct 1;92(4):741-742.
  6. Bracey A, Shatila W, Wilson J. Bleeding in patients receiving non-vitamin K oral anticoagulants: clinical trial evidence. Ther Adv Cardiovasc Dis. 2018 Dec;12(12):361-380.
  7. Shatila W, Krajcer Z. Use of an AFX aortic cuff in the endovascular treatment of aortocaval fistula secondary to abdominal aortic pseudoaneurysm. Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1352-1355.
  8. Shatila W, Krajcer Z. Peripheral Artery Disease: How Do Genes and Pharmacology Interplay? Catheter Cardiovasc Interv. 2018 Jun;91(7):1318-1319. doi: 10.1002/ccd.27649
  9. Shatila W, Krajcer Z. Chronic total occlusion: Does anti-platelet choice impact outcomes? Catheter Cardiovasc Interv. 2018 Jan 1;91(1):7-8. doi: 10.1002/ccd.27456.
  10. Shatila W, Krajcer Z. A cardiologist’s nightmare: Coronary obstruction during transcatheter aortic valve implantation: How to identify patients at highest risk for this complication. Catheter Cardiovasc Interv. 2017 Dec 1;90(7):1198-1199. doi: 10.1002/ccd.27425.
  11. Shatila W, Krajcer Z.”To close or not to close?” When should vascular closure devices be used after cardiac catheterization procedures? Catheter Cardiovasc Interv. 2017 Nov 1;90(5):766-767 doi: 10.1002/ccd.27360.
  12. Shatila W, Krajcer Z. Drug-coated balloons: “Do they still have a role in treating coronary artery disease?” Catheter Cardiovasc Interv. 2017 Sep 1;90(3):387-388.
  13. Shatila W, Krajcer Z. “ICE or not to ICE during LAAO?” What are the benefits and disadvantages of ICE during LAAO? Catheter Cardiovasc Interv. 2017 Aug 1;90(2):339-340. doi: 10.1002/ccd.27222.
  14. Peñalver JL, Shatila W, Perin E. Optical Coherence Tomographic Evaluation of Hyperacute Bivalirudin-Induced Coronary Stent Thrombosis. Tex Heart Inst J. 2017 Aug 1;44(4):266-268.
  15. Peñalver J, Shatila W, Silva GV. Percutaneous Closure of 2 Paravalvular Leaks and a Gerbode Defect after Mitral Valve Replacement for Infective Endocarditis. Tex Heart Inst J. 2017 Apr 1;44(2):153-156.
  16. Shatila W, Verma A, Adam S. Plasmapheresis in Severe Methemoglobinemia Following Occupational Exposure. Transfus Apher Sci. 2017 Feb 20.
  17. Shatila W, AlManfi A, Massumi M, Dougherty K, Parekh D, Strickman N. Endovascular Treatment of Superior Vena Cava Syndrome Using Balloon in Balloon with Palmaz Stent
  18. Shatila W, Silva GV. Advancing a Guiding Catheter Across a Mechanical Aortic Valve. Tex Heart Inst J. 2016 Apr 1;43(2):142-3
  19. Navar-Boggan AM, Rymer JA, Piccini JP, Shatila W, Ring L, Stafford JA, Al-Khatib SM, Peterson ED. Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke. Am Heart J. 2015 Jan;169(1):39-44.e2.
  20. Shatila W, Rizkallah A, Aldin ES, Tfayli A. Nonbacterial thrombotic endocarditis as the sole manifestation of stage IV gastric cancer: a case report. J Med Case Rep. 2014 Aug 4;8:267.
  21. Shatila W, Tsipis N, Eisenberg A, Cardona DM, Chudgar SM. Negative biopsies, deadly disease: metastatic angiosarcoma. Am J Med. 2014 Aug;127(8):e5-6.
  22. Shatila W, Clark A. Unexplained hypoxia in a woman presenting with acute on chronic abdominal pain. Am J Med. 2013 Aug;126(8):e1-2.

Related services

Start chat
Chat with us
Hello
I’d like to book an appointment